Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties.
alpha(1)-Acid glycoprotein (AGP) is a protein with a molecular weight of 41-43 kDa and is heavily glycosylated (45%). Due to the presence of sialic acids, it is negatively charged (pI=2.7-3.2). AGP is an acute phase protein in all mammals investigated to date. The serum concentration of AGP rises several fold during an acute phase response, the systemic answer to a local inflammatory stimulus. Also, its glycosylation pattern can change depending on the type of inflammation. The biological function of this protein is not clear. A number of activities on different type of blood cells have been described. In vivo, AGP clearly has protective effects in several models of inflammation. Here we review the data supporting an anti-inflammatory and immunomodulating role of AGP.
Hochepied
Tino
T
Department for Molecular Biomedical Research, Flanders Interuniversity Institute for Biotechnology, Ghent University, KL Ledeganckstraat 35, Belgium.
Berger
Franklin G
FG
Baumann
Heinz
H
Libert
Claude
C
D000276:Adjuvants, Immunologic / Q000378:metabolism*; D000818:Animals; D001792:Blood Platelets / Q000276:immunology / Q000378:metabolism; D016207:Cytokines / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000378:metabolism*; D009504:Neutrophils / Q000276:immunology / Q000378:metabolism; D009961:Orosomucoid / Q000737:chemistry / Q000276:immunology* / Q000378:metabolism; D014945:Wound Healing
D000276:Adjuvants, Immunologic; D016207:Cytokines; D009961:Orosomucoid